Development and prospective evaluation of a machine learning model to predict vomiting among pediatric cancer and
Adam Paul Yan1,2, Lin Lawrence Guo2, Priya Patel1,3
1Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G1X8, Canada.
Insights
A machine learning model using electronic health records can predict vomiting risk in pediatric oncology and hematopoietic cell transplant patients. This model showed consistent performance in a prospective trial, paving the way for clinical integration.
Area of Science:
- Machine learning applications in healthcare
- Predictive modeling in oncology
- Electronic health record data utilization
Background:
- Vomiting is a common side effect for pediatric patients undergoing oncology and hematopoietic cell transplant (HCT) treatments.
- Accurate prediction of vomiting risk is crucial for timely intervention and improved patient care.
Purpose of the Study:
- To develop a machine learning (ML) model using electronic health record (EHR) data to predict vomiting risk within 96 hours for pediatric oncology and HCT patients.
- To prospectively evaluate the developed ML model's performance in a silent trial.
Main Methods:
- Utilized retrospective EHR data from SEDAR (2018-2024) and conducted a prospective silent trial (2024).
- Trained and compared L2-regularized logistic regression, LightGBM, and XGBoost models.
- The outcome was defined as any vomiting within 96 hours post-prediction time.
Main Results:
- The best-performing model, LightGBM trained on all inpatients, achieved an AUROC of 0.730 retrospectively and 0.716 prospectively.
- The model utilized 2,859 features and was evaluated on 7,408 retrospective and 340 prospective admissions.
- The ML model demonstrated satisfactory predictive performance in both retrospective and prospective phases.
Conclusions:
- EHR data can effectively train ML models to predict vomiting in pediatric oncology and HCT inpatients.
- The developed ML model maintained its predictive accuracy in a prospective silent trial.
- Future work will focus on clinical workflow integration and assessing the model's impact on vomiting control.
Purpose:
Objectives were to develop a machine learning (ML) model based on electronic health record (EHR) data to predict the risk of vomiting within a 96-hour window after admission to the pediatric oncology and hematopoietic cell transplant (HCT) services using retrospective data and to evaluate the model prospectively in a silent trial.
Patients And Methods:
Admissions between 2018-06-02 to 2024-02-17 (retrospective) and 2024-05-09 to 2024-08-05 (prospective) to the oncology or HCT services were included. Data source was SEDAR, a curated and validated approach to deliver EHR data for ML. Prediction time was 08:30 the morning following admission. The outcome was any vomiting within 96 h following prediction time. We trained models using L2-regularized logistic regression, LightGBM and XGBoost. Training cohorts include the target cohort and all inpatient admissions.
Results:
There were 7,408 admissions in the retrospective phase and 340 admissions in the prospective silent trial phase. The best-performing model in the retrospective phase was the LightGBM model trained on all inpatients. The number of features in the final model was 2,859. The area-under-the-receiver-operating-characteristic curve (AUROC) was 0.730 (95% confidence interval (CI) 0.694-0.765) for the retrospective phase and 0.716 (95% CI 0.649-0.784) for the prospective silent trial phase.
Conclusions:
We found that data in the EHR could be used to develop a retrospective ML model to predict vomiting among pediatric oncology and HCT inpatients. This model retained satisfactory performance in a prospective silent trial. Future plans will include deployment into clinical workflows and determining if the model improves vomiting control.
Related Concept Videos
Pathophysiology of Vomiting
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...


